Clinical Trials Browser

Phase 2/3 × Hematopoietic Stem Cell Transplantation × Clear all

NCT04708054 2026-02-19

Venetoclax to Improve Outcomes of Fractionated Busulfan Regimen in Patients With High-Risk AML and MDS

Phase 2/3 Recruiting

MyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic

NCT00415987 2008-06-20

Hematopoietic Stem Cell Transplantation in Myeloma

Phase 2/3 Unknown

Multiple Myeloma